{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:57:48Z","timestamp":1753869468184,"version":"3.41.2"},"reference-count":47,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008220","name":"Canadian Foundation for AIDS Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Men who have sex with men (MSM) and people who inject drugs (PWID) are disproportionately impacted by the HIV epidemic in Canada. Having the second\u2010highest provincial diagnosis rate, an improved understanding of the epidemic among these populations in Qu\u00e9bec could aid ongoing elimination efforts. We estimated HIV incidence and other epidemic indicators among MSM and PWID in Montr\u00e9al and across Qu\u00e9bec using a back\u2010calculation model synthesizing surveillance data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We developed a deterministic, compartmental mathematical model stratified by age, HIV status and disease progression, and clinical care stages. Using AIDS and HIV diagnoses data, including self\u2010reported time since the last negative test and laboratory results of CD4 cell count at diagnosis, we estimated HIV incidence in each population over 1975\u20132020 by modelling a cubic M\u2010spline. The prevalence, undiagnosed fraction, fraction diagnosed that started antiretroviral treatment (ART) and median time to diagnosis were also estimated. Since the COVID\u201019 pandemic disrupted testing, we excluded 2020 data and explored this in sensitivity analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>HIV incidence in all populations peaked early in the epidemic. In 2020, an estimated 97 (95% CrI: 33\u2013227) and 266 (95% CrI: 103\u2013508) HIV acquisitions occurred among MSM in Montr\u00e9al and Qu\u00e9bec, respectively. Among PWID, we estimated 2 (95% CrI: 0\u201314) and 6 (95% CrI: 1\u201326) HIV acquisitions in those same regions. With 2020 data, unless testing rates were reduced by 50%, these estimates decreased, except among Qu\u00e9bec PWID, whose increased. Among all, the median time to diagnosis shortened to &lt;2 years before 2020 and the undiagnosed fraction decreased to &lt;10%. This fraction was higher in younger MSM, with 22% of 15\u201324 year\u2010olds living with HIV in Montr\u00e9al (95% CrI: 9\u201339%) and 31% in Qu\u00e9bec (95% CrI: 17\u201348%) undiagnosed by 2020 year\u2010end. Finally, ART access neared 100% in all diagnosed populations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>HIV incidence has drastically decreased in MSM and PWID across Qu\u00e9bec, alongside significant improvements in diagnosis and treatment coverage\u2014and the 2013 introduction of pre\u2010exposure prophylaxis. Despite this, HIV transmission continued. Effective efforts to halt this transmission and rapidly diagnose people who acquired HIV, especially among younger MSM, are needed to achieve elimination. Further, as the impacts of the COVID\u201019 pandemic on HIV transmission are understood, increased efforts may be needed to overcome these.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jia2.25994","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T05:54:19Z","timestamp":1662098059000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Measuring progress towards reaching zero new HIV acquisitions among key populations in Qu\u00e9bec (Canada) using routine surveillance data: a mathematical modelling study"],"prefix":"10.1002","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-3068","authenticated-orcid":false,"given":"Carla M.","family":"Doyle","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Population and Global Health McGill University  Montr\u00e9al Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Population and Global Health McGill University  Montr\u00e9al Qu\u00e9bec Canada"},{"name":"Direction R\u00e9gionale de Sant\u00e9 Publique de Montr\u00e9al  Montr\u00e9al Qu\u00e9bec Canada"},{"name":"Clinical Outcomes Research and Evaluation Research Institute \u2010 McGill University Health Centre  Montr\u00e9al Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael M.","family":"Milwid","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Population and Global Health McGill University  Montr\u00e9al Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Bitera","sequence":"additional","affiliation":[{"name":"Institut national de sant\u00e9 publique du Qu\u00e9bec  Qu\u00e9bec Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Lani\u00e8ce","family":"Delaunay","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Population and Global Health McGill University  Montr\u00e9al Qu\u00e9bec Canada"},{"name":"Clinical Outcomes Research and Evaluation Research Institute \u2010 McGill University Health Centre  Montr\u00e9al Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Alary","sequence":"additional","affiliation":[{"name":"Institut national de sant\u00e9 publique du Qu\u00e9bec  Qu\u00e9bec Qu\u00e9bec Canada"},{"name":"Centre de recherche du CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval  Qu\u00e9bec Qu\u00e9bec Canada"},{"name":"D\u00e9partement de m\u00e9decine sociale et pr\u00e9ventive Universit\u00e9 Laval  Qu\u00e9bec Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Lambert","sequence":"additional","affiliation":[{"name":"Direction R\u00e9gionale de Sant\u00e9 Publique de Montr\u00e9al  Montr\u00e9al Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Centre de Recherche du Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM)  Montr\u00e9al Qu\u00e9bec Canada"},{"name":"Department of Microbiology, Infectiology and Immunology University of Montr\u00e9al  Montr\u00e9al Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8492-5470","authenticated-orcid":false,"given":"Sharmistha","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Medicine St. Michael's Hospital University of Toronto  Toronto Ontario Canada"},{"name":"Institute of Medical Sciences, University of Toronto  Toronto Ontario Canada"},{"name":"Institute of Health Policy Management and Evaluation, Dalla Lana School of Public Health University of Toronto  Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8363-4388","authenticated-orcid":false,"given":"Mathieu","family":"Maheu\u2010Giroux","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Population and Global Health McGill University  Montr\u00e9al Qu\u00e9bec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,9]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"Joint United Nations Programme on HIV\/AIDS.Fast tracking combination prevention.2015."},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v47i01a11"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v45i12a01"},{"key":"e_1_2_12_5_1","unstructured":"Institut de la statistique du Qu\u00e9bec.Enqu\u00eate qu\u00e9b\u00e9coise sur la sant\u00e9 de la population 2014\u20132015.2016."},{"key":"e_1_2_12_6_1","unstructured":"Institut national de sant\u00e9 publique du Qu\u00e9bec.Programme de surveillance de l'infection par le virus de l'immunod\u00e9ficience humaine (VIH) au Qu\u00e9bec: Rapport Annuel 2019.Gouvernement du Qu\u00e9bec;2020."},{"key":"e_1_2_12_7_1","unstructured":"Government of Canada announces progress and new investments to eliminate HIV\/AIDS as a public health threat [press release]. Government of Canada December 1 2016."},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30299-1"},{"key":"e_1_2_12_9_1","unstructured":"BruemmerR.Montreal joins UNAIDS program to eradicate disease by 2030. Montreal Gazette [Internet].2017[cited 2019 April 29]. Available from:http:\/\/montrealgazette.com\/news\/local\u2010news\/montreal\u2010to\u2010join\u2010unaids\u2010program\u2010to\u2010eradicate\u2010disease\u2010by\u20102030."},{"key":"e_1_2_12_10_1","unstructured":"Montr\u00e9al signe la D\u00e9claration de Paris visant \u00e0 l'\u00e9radication du VIH\/SIDA [press release]. Ville de Montr\u00e9al December 1 2017."},{"key":"e_1_2_12_11_1","unstructured":"Ville Sans SIDA Montreal.Common Action Plan 2019\u20132020.2018."},{"volume-title":"Estimating HIV incidence using HIV case surveillance","year":"2015","author":"WHO Working Group on HIV Incidence Assays","key":"e_1_2_12_12_1"},{"issue":"1","key":"e_1_2_12_13_1","article-title":"Using HIV diagnostic data to estimate HIV incidence: method and simulation","volume":"3","author":"Yan P","year":"2011","journal-title":"Stat Commun Infect Dis"},{"volume-title":"Portrait des infections transmissibles sexuellement et par le sang (ITSS) au Qu\u00e9bec 2018 et projections 2019","year":"2020","author":"Institut national de sant\u00e9 publique du Qu\u00e9bec","key":"e_1_2_12_14_1"},{"volume-title":"HIV\/AIDS EPI UPDATES \u2010 Chapter 1: national HIV prevalence and incidence estimates for 2011","year":"2014","author":"Public Health Agency of Canada","key":"e_1_2_12_15_1"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2019.02.002"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000324"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000854"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001437"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-6868-4"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/00031305.2017.1375990"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v040.i08"},{"key":"e_1_2_12_23_1","first-page":"425","article-title":"Monotone regression splines in action","author":"Ramsay JO","year":"1988","journal-title":"Stat Sci"},{"volume-title":"Consortium to characterize injection drug users in Canada (Montreal, Toronto and Vancouver). Final report","year":"1998","author":"Remis R","key":"e_1_2_12_24_1"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.06.022"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305379"},{"key":"e_1_2_12_27_1","unstructured":"World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach\u20102006 revision.2006."},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000008"},{"volume-title":"Guidelines for the use of antiretroviral agents in HIV\u20101\u2010infected adults and adolescents","year":"2013","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","key":"e_1_2_12_29_1"},{"volume-title":"Guidelines for the use of antiretroviral agents in HIV\u20101\u2010infected adults and adolescents","year":"2016","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","key":"e_1_2_12_30_1"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002386"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10107-018-1241-0"},{"volume-title":"Compact numerical methods for computers","year":"1990","author":"Nash JC","key":"e_1_2_12_33_1"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30315-5"},{"key":"e_1_2_12_35_1","unstructured":"Programme de surveillance du sida du Qu\u00e9bec. Surveillance des cas de syndrome d'immunod\u00e9ficience acquise (SIDA) cas cumulatifs 1979\u20132003.Direction g\u00e9n\u00e9rale de la sant\u00e9 publique Minist\u00e8re de la Sant\u00e9 et des Services sociaux.2003."},{"key":"e_1_2_12_36_1","unstructured":"Programme de surveillance du sida du Qu\u00e9bec. Surveillance des cas de syndrome d'immunod\u00e9ficience acquise (SIDA) cas cumulatifs 1979\u20132003: Montr\u00e9al\u2010Centre (R\u00e9gion 06).Direction g\u00e9n\u00e9rale de la sant\u00e9 publique Minist\u00e8re de la Sant\u00e9 et des Services sociaux.2003."},{"key":"e_1_2_12_37_1","unstructured":"LambertG CoxJ Messier\u2010PeetM ApelianH MoodieEEM the members of the Engage research team.Engage Montr\u00e9al Portrait of the sexual health of men who have sex with men in Greater Montr\u00e9al Cycle 2017\u20132018 Highlights.Direction r\u00e9gionale de sant\u00e9 publique CIUSSS du Centre\u2010Sud\u2010de\u2010l\u2019\u00cele\u2010de\u2010Montr\u00e9al;2019."},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25699"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30327-8"},{"issue":"3","key":"e_1_2_12_40_1","first-page":"4522","article-title":"Geographic differences in the experiences of HIV\u2010related stigma for women living with HIV in northern and rural communities of Ontario, Canada","volume":"18","author":"Jaworsky D","year":"2018","journal-title":"Rural Remote Health."},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00321-4"},{"key":"e_1_2_12_42_1","unstructured":"LinthwaiteB SangareN TrottierH BarilJG DurandM KleinM et\u00a0al.In\u2010care HIV cascades for the City of Montreal: data from the Cohorte Montr\u00e9alaise.2018."},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v47i56a02"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07207-7"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200208150-00007"},{"volume-title":"Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection: \u00e9pid\u00e9miologie du VIH de 1995 \u00e0 2018 et \u00e9pid\u00e9miologie du VHC de 2003 \u00e0 2018","year":"2021","author":"Leclerc P","key":"e_1_2_12_46_1"},{"key":"e_1_2_12_47_1","article-title":"How can progress towards ending the HIV epidemic in the United States be monitored?","author":"Mitchell KM","year":"2021","journal-title":"Clin Infect Dis"},{"key":"e_1_2_12_48_1","unstructured":"Public Health Agency of Canada.National Report: findings from the survey on the impact of COVID\u201019 on the delivery of STBBI prevention testing and treatment including harm reduction services in Canada.2022."}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25994","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.25994","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T05:50:48Z","timestamp":1692683448000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.25994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1002\/jia2.25994"],"URL":"https:\/\/doi.org\/10.1002\/jia2.25994","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"type":"print","value":"1758-2652"},{"type":"electronic","value":"1758-2652"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"2022-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e25994"}}